BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 38534703)

  • 1. Rethinking Hidradenitis Suppurativa Management: Insights into Bacterial Interactions and Treatment Evolution.
    Huynh FD; Damiani G; Bunick CG
    Antibiotics (Basel); 2024 Mar; 13(3):. PubMed ID: 38534703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.
    Gulliver W; Zouboulis CC; Prens E; Jemec GB; Tzellos T
    Rev Endocr Metab Disord; 2016 Sep; 17(3):343-351. PubMed ID: 26831295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hidradenitis Suppurativa at an Uncommon Site: A Review of Its Clinical Features, Diagnostic Difficulties, and Management.
    Harvey LM; Fortson JK
    Cureus; 2021 Oct; 13(10):e18704. PubMed ID: 34790460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory Drugs in the Treatment of Hidradenitis Suppurativa-Possibilities and Limitations.
    Świerczewska Z; Lewandowski M; Surowiecka A; Barańska-Rybak W
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hidradenitis suppurativa: a review of current treatment options.
    Lewandowski M; Świerczewska Z; Barańska-Rybak W
    Int J Dermatol; 2022 Sep; 61(9):1152-1164. PubMed ID: 35128643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Therapeutic Approaches and Targets for the Treatment of Hidradenitis Suppurativa.
    Giuffrida R; Cannavò SP; Coppola M; Guarneri C
    Curr Pharm Biotechnol; 2021; 22(1):59-72. PubMed ID: 32368973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unilateral Breast Skin Changes in Patient With Hidradenitis Suppurativa: Malignancy Versus Lymphedema.
    Ederle A; Dreher K; Valdes-Rodriguez R
    Cureus; 2021 Jul; 13(7):e16232. PubMed ID: 34367830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa.
    Molinelli E; Sapigni C; D'Agostino GM; Brisigotti V; Rizzetto G; Bobyr I; Cirioni O; Giacometti A; Brescini L; Mazzanti S; Offidani A; Simonetti O
    Antibiotics (Basel); 2022 Nov; 11(11):. PubMed ID: 36358228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hidradenitis suppurativa for the nondermatology clinician.
    Patel K; Liu L; Ahn B; Silfvast-Kaiser AS; Paek SY
    Proc (Bayl Univ Med Cent); 2020 Jul; 33(4):586-591. PubMed ID: 33100533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Skin and Gut Microbiome in Hidradenitis Suppurativa: Current Understanding and Future Considerations for Research and Treatment.
    Luck ME; Tao J; Lake EP
    Am J Clin Dermatol; 2022 Nov; 23(6):841-852. PubMed ID: 36116091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Characteristics and Trends in Treatment Response of Hidradenitis Suppurativa Patients: A Southern US Cohort Study.
    Peterson GC; Preston A; Frieder J; Wang X; Paek SY
    Dermatology; 2020; 236(5):413-420. PubMed ID: 31935718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hidradenitis Suppurativa: An Interdisciplinary Problem in Dermatology, Gynecology, and Surgery-Pathogenesis, Comorbidities, and Current Treatments.
    Nowak-Liduk A; Kitala D; Ochała-Gierek G; Łabuś W; Bergler-Czop B; Pietrauszka K; Niemiec P; Szyluk K; Gierek M
    Life (Basel); 2023 Sep; 13(9):. PubMed ID: 37763299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic Antibiotic Therapy in Hidradenitis Suppurativa: A Review on Treatment Landscape and Current Issues.
    Molinelli E; De Simoni E; Candelora M; Sapigni C; Brisigotti V; Rizzetto G; Offidani A; Simonetti O
    Antibiotics (Basel); 2023 May; 12(6):. PubMed ID: 37370297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.
    Zouboulis CC; Desai N; Emtestam L; Hunger RE; Ioannides D; Juhász I; Lapins J; Matusiak L; Prens EP; Revuz J; Schneider-Burrus S; Szepietowski JC; van der Zee HH; Jemec GB
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):619-44. PubMed ID: 25640693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New perspectives on the treatment of hidradenitis suppurativa.
    Amat-Samaranch V; Agut-Busquet E; Vilarrasa E; Puig L
    Ther Adv Chronic Dis; 2021; 12():20406223211055920. PubMed ID: 34840709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hidradenitis suppurativa/acne inversa: An update].
    Kirschke J; Hessam S; Bechara FG
    Hautarzt; 2015 Jun; 66(6):413-22. PubMed ID: 25877488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in the Management of Perianal Hidradenitis Suppurativa in an African American Male: A Case Report.
    Russell N; Kpughur-Tule N; Ravichandar E; Dorta Torres G; Tiesenga F
    Cureus; 2023 Sep; 15(9):e45788. PubMed ID: 37872932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CME Dermatology 23: Hidradenitis suppurativa].
    Dahmen RA; Lautenschlager S
    Praxis (Bern 1994); 2021; 110(7):363-372. PubMed ID: 34019444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CME Dermatology 23/Answers: Hidradenitis suppurativa].
    Dahmen RA; Lautenschlager S
    Praxis (Bern 1994); 2021 Jun; 110(8):471-472. PubMed ID: 34107755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.